Clinical Trial Update: Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial studying cytotoxic T cells with interleukin-2 in adults with recurrent brain tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors

Drugs mentioned

• Cytotoxic T cells
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED